As federal health officials vow to overhaul the U.S. food supply, they’re taking a new look at infant formula.

The Food and Drug Administration is requiring Pfizer and Moderna to expand warnings on the labels of their COVID-19 vaccines for the risk of heart inflammation in adolescents and young men.

WASHINGTON (AP) — U.S. health regulators announced an effort Tuesday to phase out ingestible fluoride supplements sometimes used to strengthen children’s teeth, opening a new front in Health Secretary Robert F. Kennedy Jr.’s effort against a mainstay of dental care.

The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a synthetic dye that gives food and drinks their bright red cherry color but has been linked to cancer in animals.

The U.S. Food and Drug Administration said it requested information on so-called forever chemicals found in some seafood, to understand their risks better.

The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape maker.

Neuralink has FDA clearance to start messing with people’s heads—and not just figuratively.

An investigation has raised concerns about the 'cozy relationship' between the Food and Drug Association (FDA) and Moderna during the Covid pandemic.

The United States Court of Appeals for the Third Circuit in Philadelphia has rejected a Chapter 11 petition that was submitted by a recently established subsidiary of Johnson & Johnson (J&J) named LTL Management. If approved, the petition would have permitted the pharma giant to avert having to pay out billions of dollars in trial accolades for its cancer-causing baby powder. However, the petition has been rejected.

Jan 23 (Reuters) - The U.S. health regulator on Monday proposed one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it aims to simplify the country's COVID-vaccine strategy.

Some vaccine advisers to the federal government say they're "disappointed" and "angry" that government scientists and the pharmaceutical company Moderna didn't present a set of infection data on the company's new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.

Covid-19 vaccines and drugs were developed at “warp speed” and now experts are concerned that the US Food and Drug Administration inspected too few clinical trial sites. Maryanne Demasi reports

One day after the Biden administration said it would develop a rule requiring tobacco companies to reduce nicotine levels in cigarettes, a new report via WSJ said the Food and Drug Administration (FDA) is preparing to order Juul Labs Inc. to take its e-cigarettes off the U.S. market.

CDC and FDA officials 'altered' Covid guidance and even 'suppressed' findings related to the virus due to political pressure, a bombshell report suggests.

Independent testing has found hundreds of popular personal care items in the US to be contaminated with benzene, a highly carcinogenic chemical, prompting several big brands to voluntarily recall dozens of products in recent months.

Food and Drug Administration (FDA) Executive Officer Christopher Cole was caught on undercover camera by Project Veritas, where he revealed that his agency plans to announce that annual Covid-19 vaccinations will become official policy.

Moderna's Covid-19 vaccine has received full approval from the US Food and Drug Administration, according to news releases from the FDA and Moderna.

Somewhere on the other side of the growing heap of government and pharma lawyers is transparency.

The US drugs regulator has rescinded its authorisation for the monoclonal antibody treatments made by Eli Lilly and Regeneron, which proved highly effective at fighting earlier strains of Covid-19 but do not work well against the Omicron variant.

A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer’s COVID-19 vaccine, imposing a dramatically accelerated schedule that should result in the release of all information within about eight months.